Barclays’s Polaryx Therapeutics Inc PLYX Stock Holding History

Barclays’s Portfolio PLYX Stock Details PLYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19	Buy	+9	New	+$20	﹤0.01%	5132

Other funds holding PLYX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Barclays's PLYX Position: Q3 2026 in Review

Barclays opened a new position in Polaryx Therapeutics Inc (PLYX) in Q3 2026: 9 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #5132 among its holdings.

3 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

Barclays held 9 shares of Polaryx Therapeutics Inc worth $19 as of Q3 2026.
Polaryx Therapeutics Inc was a new Barclays position in Q3 2026.
Polaryx Therapeutics Inc made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5132 holding.
3 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.